Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation

Mitigation Effects of a Novel Herbal Medicine, Hepad, on Neuroinflammation, Neuroapoptosis, and Neuro-Oxidation

Parkinson’s disease (PD), a common adult-onset neurodegenerative disorder with complex pathological mechanisms, is characterized by the degeneration of dopaminergic nigrostriatal neurons. The present study demonstrated that the herbal medicines Hepad 1 and 2 protected against 1-methyl-4-ph...

Full description

Bibliographic Details
Main Authors:	Da Hye Song, Gyeong-Ji Kim, Kwon Jai Lee, Jae Soo Shin, Dong-Hee Kim, Byung-Jun Park, Jeung Hee An
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	Molecules
Subjects:	Parkinson’s disease 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Hepad Mitigation effect SH-SY5Y cells Substantia nigra
Online Access:	https://www.mdpi.com/1420-3049/23/11/2920

Similar Items

Vitamin E Analog Trolox Attenuates MPTP-Induced Parkinson’s Disease in Mice, Mitigating Oxidative Stress, Neuroinflammation, and Motor Impairment
by: Abubakar Atiq, et al.
Published: (2023-06-01)

Neuroprotective Effects of Nicotinamide against MPTP-Induced Parkinson’s Disease in Mice: Impact on Oxidative Stress, Neuroinflammation, Nrf2/HO-1 and TLR4 Signaling Pathways
by: Inayat Ur Rehman, et al.
Published: (2022-11-01)

Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson’s disease
by: Michael D. Boska, et al.
Published: (2007-06-01)

Whole Transcriptome Analysis of Substantia Nigra in Mice with MPTP-Induced Parkinsonism Bearing Defective Glucocerebrosidase Activity
by: Tatiana Usenko, et al.
Published: (2023-07-01)

DIFFERENTIALLY EXPRESSED GENES AND THEIR SIGNIFICANCE THE SUBSTANTIA NIGRA OF MICE WITH 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSON’S DISEASE
by: LI Beining, YAO Zhengyang, JIAO Qian, CHEN Xi, JIANG Hong, DU Xixun
Published: (2023-04-01)

Isolation of living dopaminergic neurons labeled with a fluorescent ligand of the dopamine transporter from mouse substantia nigra as a new tool for basic and applied research
by: Dmitry Troshev, et al.
Published: (2022-12-01)

Icaritin Provides Neuroprotection in Parkinson’s Disease by Attenuating Neuroinflammation, Oxidative Stress, and Energy Deficiency
by: Hao Wu, et al.
Published: (2021-03-01)

Beneficial effects of L-arginine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neuronal degeneration in substantia nigra of Balb/c mice
by: Javad Hami, et al.
Published: (2016-01-01)

Effect of Eleutheroside E on an MPTP-Induced Parkinson’s Disease Cell Model and Its Mechanism
by: Yi Yao, et al.
Published: (2023-04-01)

Análise histomorfométrica do músculo sóleo de ratos submetidos ao modelo animal de parkinsonismo induzido pelo MPTP
by: Ana Paula Cunha Loureiro, et al.

Electroacupuncture at GB34 modulates neurogenesis and BDNF-ERK signaling in a mouse model of Parkinson's disease
by: Yukyoung Lee, et al.
Published: (2023-05-01)

Neuroprotective effect of ketamine/xylazine on two rat models of Parkinson's disease
by: M.M. Ferro, et al.
Published: (2007-01-01)

Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
by: Seulah Lee, et al.
Published: (2021-02-01)

Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model
by: Ye Lee Jun, et al.
Published: (2015-04-01)

Differential Effects of Paraquat, Rotenone, and MPTP on Cellular Bioenergetics of Undifferentiated and Differentiated Human Neuroblastoma Cells
by: Ekramy Elmorsy, et al.
Published: (2023-12-01)

The Sphingolipid Asset Is Altered in the Nigrostriatal System of Mice Models of Parkinson’s Disease
by: Victor Blokhin, et al.
Published: (2022-01-01)

Comparative analysis of dose-dependent neurotoxic response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 N mice derived from three different sources
by: Dong-Joo Hwang, et al.
Published: (2019-07-01)

Gastric Enteric Glial Cells: A New Contributor to the Synucleinopathies in the MPTP-Induced Parkinsonism Mouse
by: Yang Heng, et al.
Published: (2022-11-01)

Defining Specific Cell States of MPTP-Induced Parkinson’s Disease by Single-Nucleus RNA Sequencing
by: Yunxia Guo, et al.
Published: (2022-09-01)

MPTP-Treated Zebrafish Recapitulate ‘Late-Stage’ Parkinson’s-like Cognitive Decline
by: Alim A. O. Bashirzade, et al.
Published: (2022-02-01)

Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration
by: Dong-Young Choi, et al.
Published: (2013-01-01)

Compensatory Processes in Striatal Neurons Expressing the Tyrosine Hydroxylase Gene in Transgenic Mice in a Model of Parkinson’s Disease
by: Dmitry Troshev, et al.
Published: (2023-11-01)

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
by: Yang Tan, et al.
Published: (2020-02-01)

Encapsulated GDNF-producing C2C12 cells for Parkinson's disease: a pre-clinical study in chronic MPTP-treated baboons
by: Haruhiko Kishima, et al.
Published: (2004-07-01)

Neuroprotective Effects of a Traditional Multi-Herbal Medicine Kyung-Ok-Ko in an Animal Model of Parkinson's Disease: Inhibition of MAPKs and NF-κB Pathways and Activation of Keap1-Nrf2 Pathway
by: Jong Hee Choi, et al.
Published: (2018-12-01)

Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice
by: Wang Qingshan, et al.
Published: (2012-06-01)

Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson’s Disease via Lysophosphatidic Acid Receptors
by: Jong Hee Choi, et al.
Published: (2018-05-01)

Epimedin B exerts neuroprotective effect against MPTP-induced mouse model of Parkinson's disease: GPER as a potential target
by: Mei Zhang, et al.
Published: (2022-12-01)

Anti-Inflammatory Effect of IKK-Activated GSK-3β Inhibitory Peptide Prevented Nigrostriatal Neurodegeneration in the Rodent Model of Parkinson’s Disease
by: Seulah Lee, et al.
Published: (2022-01-01)

Decoupling neuronal oscillations during subthalamic nucleus stimulation in the parkinsonian primate
by: A. Moran, et al.
Published: (2012-01-01)

Date preliminare privind unele manifestări ale durerii într-un model de șobolan MPTP-indus a bolii Parkinson
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Changes of neurons and blood vessels of human substantia nigra in aging: Morphometric study
by: Krivokuća Zdenka, et al.
Published: (2017-01-01)

Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson’s disease
by: Pingping Song, et al.
Published: (2016-01-01)

Lmx1b Influences Correct Post-mitotic Coding of Mesodiencephalic Dopaminergic Neurons
by: Iris Wever, et al.
Published: (2019-03-01)

Changes in cytoplasmic and extracellular neuromelanin in human substantia nigra with normal aging
by: Dmitrii E. Korzhevskii, et al.
Published: (2021-09-01)

MRI Findings in Parkinson’s Disease: Radiologic Assessment of Nigrostriatal Degeneration
by: Yun Jung Bae, et al.
Published: (2022-05-01)

Mitochondrial DNA mutations in Parkinson's disease brain
by: David K. Simon, et al.
Published: (2017-04-01)

Increased vulnerability of nigrostriatal terminals in DJ-1-deficient mice is mediated by the dopamine transporter
by: Amy B. Manning-Boğ, et al.
Published: (2007-08-01)

Therapeutic Potential of Repeated Intravenous Transplantation of Human Adipose-Derived Stem Cells in Subchronic MPTP-Induced Parkinson’s Disease Mouse Model
by: Hyunjun Park, et al.
Published: (2020-10-01)

Rhes Counteracts Dopamine Neuron Degeneration and Neuroinflammation Depending on Gender and Age
by: Giulia Costa, et al.
Published: (2018-05-01)